Archives

by in
Entry Author Date Location
FDA Panel Votes Against Arena’s Weight-Loss Drug, ImThera Encouraged by Early Test Results, Novartis Wins FDA Approval for MS Pill, & More San Diego Life Sciences News 09/23/10 San Diego
Biogen Rival Reaches Finish Line with Oral Drug for MS 09/22/10 Boston
PerkinElmer Sells Unit for $500M, Aveo Stock Climbs, Pfizer Buys FoldRx, & More Boston-Area Life Sciences News 09/03/10 Boston
Biogen Idec Strikes Potential $345M Deal with Knopp to Develop ALS Drug 08/18/10 Boston
How Much Would You Pay for Genzyme? 07/26/10 Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Allozyne Breaks Silence, Accelerator’s Mini-Golf Hijinks, Maveron’s Vision for Primary Care, & More Seattle-Area Life Sciences News 07/15/10 Seattle
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline 07/14/10 Seattle
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News 07/08/10 San Diego
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve 07/01/10 Boston
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote 06/09/10 Boston
Biogen’s CEO Retires Tomorrow, COO to Follow 06/07/10 Boston
Tolera Therapeutics, Cleveland Clinic Spinoff Focused on Immune Disorders, Raises $4M 06/04/10 Detroit
An OVP IPO is Brewing, Allozyne Doing Fine, VLST Finds Second Partner, & More Tidbits from the OVP Tech Summit 05/04/10 Seattle
Icahn Calls Genzyme’s Manufacturing “Broken,” Advises Against Termeer’s Re-Election to Board 05/04/10 Boston
Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works 04/27/10 Boston
Kineta Nabs $600K NIH Grant 04/05/10 Seattle
PatientsLikeMe Launching Transplant Community 03/09/10 Boston
Roche, Biogen Halt Arthritis Study 03/08/10 Boston
PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients 02/10/10 Boston
Biogen Idec Advances First Regenerative MS Medicine into Human Study 01/27/10 Boston
Millennium, In a New Role, Flexes Global Muscle to Cut Deal With Seattle Genetics 01/26/10 Boston
Tysabri’s PML Count Climbs to 28, and Some Reflections From Biogen Idec’s Departing CEO 01/06/10 Boston
Biogen Idec CEO Jim Mullen Stepping Down, After Tumultuous Year of Shareholder Activism 01/04/10 Boston
Biogen Idec Bid for Facet Biotech Shot Down, But the Show’s Not Over 12/17/09 Boston
Biogen Prepared for Proxy Battle for Facet Biotech 12/15/09 Boston
Facet Rejects Biogen’s Latest Offer 12/10/09 Boston
Biogen Fattens Offer to Buy Facet Biotech 12/03/09 Boston
Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News 11/25/09 Boston
Page 3 of 6 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.